| 产品详情 |
| Edit |   |
|---|
| Product Name | Regadenoson (2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]-adenosine) |
|---|
| Description | Purity ~98%. Regadenoson is a selective and potent A2A adenosine receptor agonist (1). The adenosine A2A receptor is a G-protein-coupled receptor and a key therapeutic target for oncologic, inflammatory, Parkinson's and cardiovascular diseases (2). In rodent studies, it has been shown that co-administration of Regadenoson with Temozolomide (T017775) can increase Temozolomide concentration in the brain (3). Synonyms: 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]-adenosine |
|---|
| Size | 5mg, 10mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]-adenosine |
|---|
| Gene, Accession, CAS # | CAS: 390.35 |
|---|
| Catalog # | R1375 |
|---|
| Price | |
|---|
| Order / More Info | Regadenoson (2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]-adenosine) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|